Letters Chronic fatigue treatment trial

What’s the problem with sharing research committee’s discussions?

BMJ 2013; 347 doi: http://dx.doi.org/10.1136/bmj.f5740 (Published 25 September 2013) Cite this as: BMJ 2013;347:f5740
  1. Allan House, academic psychiatrist1
  1. 1University of Leeds, Leeds LS2 9LJ, UK
  1. a.o.house{at}leeds.ac.uk

I struggle to see the logic here,1 mainly because I can’t think what would be minuted in a professionally conducted meeting that could not be shared later, once the usual conditions about third party information and data still being prepared for publication have been applied. The debate might move on with some specific, even if fictitious, examples.

Most people are (rightly) deeply suspicious about non-specific appeals to academic freedom or sensitivity of information as an explanation for opacity in public life.

Notes

Cite this as: BMJ 2013;347:f5740

Footnotes

  • Competing interests: None declared.

References